P Voabil, M de Bruijn, LM Roelofsen, SH Hendriks… - Nature medicine, 2021 - nature.com
Inhibitors of the PD-1–PD-L1 axis have been approved as therapy for many human cancers.
In spite of the evidence for their widespread clinical activity, little is known about the …